TitletownTech — 2026 Investments
5 investments dated 2026 · listed companies and verified rows first · show all
Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection.
BiotechHealthtechMedical DevicesCharlottesville, US
Co-investorsVirginia Venture Partners
Ateios develops electrode manufacturing techniques designed to accelerate production speed, reduce carbon emissions, and decrease the physical footprint of battery manufacturing and gigafactories.
Advanced ManufacturingCleantechEnergyMedical DevicesNew MaterialsLa Jolla, US
Terry Taber(CTO)
Co-investorsCarat Venture PartnersCharmides CapitalCowtown AngelsE8 AngelsElevate VenturesGood Growth Capital+7 more
Quantum magnetometer-based, GPS-free navigation systems delivering spoof-resistant positioning for defense, aviation and drones.
Deep TechHardwareQuantum ComputingMadison, US
Aishwarya Das(Mr. Das is the Chief Operating Officer)inSanket Deshpande(Executive Officer, Director)
Co-investorsAutomotive Ventures MobilityquantumEDGE VenturesRiceberg Ventures PremiergradCapital
Shelfmark provides AI-based visual inspection systems that detect, predict, and prevent defects in continuously manufactured "web-based" rolled goods such as textiles, webbings, labels, films, trusses, and coil coatings.
Advanced ManufacturingAI & Machine LearningHardwarePittsburgh, US
Patrick O'Donnell(Executive Officer, Director, Promoter)PatinCraig Markovitz(Executive Officer, Director)in
BoardAnthony Santaro(Director)in
Co-investorsArmory Square VenturesGrand VenturesCultivation Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















